Home > Amicus Therapeutics Salary

Amicus Therapeutics Salary

  • 85
  • 93
  • 82
Amicus Therapeutics average salary is $73,750, median salary is $73,750 with a salary range from $72,500 to $75,000.
Amicus Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Amicus Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
72,500
Average
73,750
Median
73,750
High
75,000
Total 2 Amicus Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Dean Of Whizin Center For Continuing Education/director 75,000-75,000 CRANBURY, NJ, 08512 2016 Amicus Therapeutics Dean Of Whizin Center For Continuing Education/director Salaries (1)
Amicus Therapeutics CRANBURY, NJ Salaries
Director Inst.on American-jewish Israeli Relations 72,500-72,500 Los Angeles, CA, 90001 2012 Amicus Therapeutics Director Inst.on American-jewish Israeli Relations Salaries (1)
Amicus Therapeutics Los Angeles, CA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Amicus Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Amicus Therapeutics Jobs
See more Amicus Therapeutics Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Amicus Therapeutics... Information
  • Amicus Therapeutics
  • Industry: BioTech/Drugs
  • City: Cranbury, NJ
  • Amicus was established in April 2002 with seed financing provided by CHL Medical Partners II, a venture capital fund managed by Collinson, Howe & Lennox, and is focused on the development of orally-active, small molecule drugs capable of restoring normal function to mutant proteins. Amicus was founded to capitalize on the discovery that many diseases of genetic origin are caused by missense mutations and other rescuable mutations that result in the misfolding of a protein/enzyme. These misfolded mutant proteins become targeted for degradation before reaching their normal site of action, leading to the disease phenotype. Pharmacological Chaperones are designed to